An influenza A (H3N2) virus outbreak in the Kingdom of Cambodia during the COVID-19 pandemic of 2020.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 03 11 2020
revised: 17 11 2020
accepted: 20 11 2020
pubmed: 30 11 2020
medline: 25 2 2021
entrez: 29 11 2020
Statut: ppublish

Résumé

Global influenza virus circulation decreased during the COVID-19 pandemic, possibly due to widespread community mitigation measures. Cambodia eased some COVID-19 mitigation measures in June and July 2020. On 20 August a cluster of respiratory illnesses occurred among residents of a pagoda, including people who tested positive for influenza A but none who were positive for SARS-CoV-2. A response team was deployed on 25 August 2020. People with influenza-like illness (ILI) were asked questions regarding demographics, illness, personal prevention measures, and residential arrangements. Respiratory swabs were tested for influenza and SARS-Cov-2 by real-time reverse transcription PCR, and viruses were sequenced. Sentinel surveillance data were analyzed to assess recent trends in influenza circulation in the community. Influenza A (H3N2) viruses were identified during sentinel surveillance in Cambodia in July 2020 prior to the reported pagoda outbreak. Among the 362 pagoda residents, 73 (20.2%) ILI cases were identified and 40 were tested, where 33/40 (82.5%) confirmed positive for influenza A (H3N2). All 40 were negative for SARS-CoV-2. Among the 73 residents with ILI, none were vaccinated against influenza, 47 (64%) clustered in 3/8 sleeping quarters, 20 (27%) reported often wearing a mask, 27 (36%) reported often washing hands, and 11 (15%) reported practicing social distancing. All viruses clustered within clade 3c2.A1 close to strains circulating in Australia in 2020. Circulation of influenza viruses began in the community following the relaxation of national COVID-19 mitigation measures, and prior to the outbreak in a pagoda with limited social distancing. Continued surveillance and influenza vaccination are required to limit the impact of influenza globally.

Sections du résumé

BACKGROUND BACKGROUND
Global influenza virus circulation decreased during the COVID-19 pandemic, possibly due to widespread community mitigation measures. Cambodia eased some COVID-19 mitigation measures in June and July 2020. On 20 August a cluster of respiratory illnesses occurred among residents of a pagoda, including people who tested positive for influenza A but none who were positive for SARS-CoV-2.
METHODS METHODS
A response team was deployed on 25 August 2020. People with influenza-like illness (ILI) were asked questions regarding demographics, illness, personal prevention measures, and residential arrangements. Respiratory swabs were tested for influenza and SARS-Cov-2 by real-time reverse transcription PCR, and viruses were sequenced. Sentinel surveillance data were analyzed to assess recent trends in influenza circulation in the community.
RESULTS RESULTS
Influenza A (H3N2) viruses were identified during sentinel surveillance in Cambodia in July 2020 prior to the reported pagoda outbreak. Among the 362 pagoda residents, 73 (20.2%) ILI cases were identified and 40 were tested, where 33/40 (82.5%) confirmed positive for influenza A (H3N2). All 40 were negative for SARS-CoV-2. Among the 73 residents with ILI, none were vaccinated against influenza, 47 (64%) clustered in 3/8 sleeping quarters, 20 (27%) reported often wearing a mask, 27 (36%) reported often washing hands, and 11 (15%) reported practicing social distancing. All viruses clustered within clade 3c2.A1 close to strains circulating in Australia in 2020.
CONCLUSIONS CONCLUSIONS
Circulation of influenza viruses began in the community following the relaxation of national COVID-19 mitigation measures, and prior to the outbreak in a pagoda with limited social distancing. Continued surveillance and influenza vaccination are required to limit the impact of influenza globally.

Identifiants

pubmed: 33249287
pii: S1201-9712(20)32491-7
doi: 10.1016/j.ijid.2020.11.178
pmc: PMC10290288
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-357

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Published by Elsevier Ltd.

Références

Influenza Other Respir Viruses. 2019 Sep;13(5):465-476
pubmed: 31251478
Vaccine. 2008 Sep 12;26 Suppl 4:D31-4
pubmed: 19230156
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Emerg Infect Dis. 2020 Aug;26(8):1933-1935
pubmed: 32339092
PLoS One. 2014 Oct 23;9(10):e110713
pubmed: 25340711
Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):97-104
pubmed: 20578488
MMWR Recomm Rep. 2017 Apr 21;66(1):1-34
pubmed: 28426646
Influenza Other Respir Viruses. 2012 Jul;6(4):257-67
pubmed: 22188875
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305-1309
pubmed: 32941415
Travel Med Infect Dis. 2020 Jul - Aug;36:101751
pubmed: 32473312
Clin Infect Dis. 2021 Jul 1;73(1):e132-e140
pubmed: 32472687
MMWR Recomm Rep. 2020 Aug 21;69(8):1-24
pubmed: 32820746
Vaccine. 2020 Sep 3;38(39):6078-6079
pubmed: 32773245

Auteurs

L Y Sovann (LY)

Ministry of Health, Cambodia.

B Sar (B)

United States Centers for Disease Control and Prevention.

V Kab (V)

World Health Organization, Cambodia.

S Yann (S)

Virology Unit, Institute Pasteur of Cambodia, Cambodia.

M Kinzer (M)

United States Centers for Disease Control and Prevention.

P Raftery (P)

World Health Organization, Cambodia.

R Albalak (R)

United States Centers for Disease Control and Prevention.

S Patel (S)

World Health Organization, Cambodia.

P Long Hay (PL)

World Health Organization, Cambodia.

H Seng (H)

Ministry of Health, Cambodia.

S Um (S)

Ministry of Health, Cambodia.

S Chin (S)

Ministry of Health, Cambodia.

D Chau (D)

Ministry of Health, Cambodia.

A Khalakdina (A)

World Health Organization, Cambodia.

E Karlsson (E)

Virology Unit, Institute Pasteur of Cambodia, Cambodia.

S J Olsen (SJ)

United States Centers for Disease Control and Prevention.

J A Mott (JA)

United States Centers for Disease Control and Prevention. Electronic address: jmott@cdc.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH